Lorenzo Marinho Morais
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lorenzo Marinho Morais has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alissa Elen Formiga Moura
Universidade Federal do Ceará, Hospital Universitário Walter Cantídio, Departamento de Neurologia, Fortaleza CE, Brazil
1 shared publication - Antônio Alves Sobreira-Neto
Universidade Federal do Ceará, Brazil
1 shared publication - Chiara Gübel Portugal
Universidade Federal do Ceará, Brazil
1 shared publication - Emanuel de Assis Bertulino Martins Gomes
Universidade Federal do Ceará, Brazil
1 shared publication - Emmanuelle Silva Tavares Sobreira
Universidade Christus (Unichristus), Fortaleza, Ceará, Brasil
1 shared publication - Esther de Alencar Araripe Falcão Feitosa
Centro Universitário Christus, Brazil; Universidade de Fortaleza, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 18, e20230076
Long COVID: neurological manifestations - an updated narrative review
Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Dementia & Neuropsychologia
- Vol. 18, e20230076
Open AccessLong COVID: neurological manifestations - an updated narrative review
Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.